A biophysical approach to the optimisation of dendritic-tumour cell electrofusion
- 4 August 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 346 (3) , 829-839
- https://doi.org/10.1016/j.bbrc.2006.05.193
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Non–Small-Cell Lung Cancer Vaccine Therapy: A Concise ReviewJournal of Clinical Oncology, 2005
- Tumor-dendritic cell fusion as a basis for cancer immunotherapyOtolaryngology -- Head and Neck Surgery, 2005
- Generation of dendritic cell?tumor cell hybrids by electrofusion for clinical vaccine applicationCancer Immunology, Immunotherapy, 2004
- Quantification of cell hybridoma yields with confocal microscopy and flow cytometryBiochemical and Biophysical Research Communications, 2004
- Comparative Analysis of Antigen Loading Strategies of Dendritic Cells for Tumor ImmunotherapyJournal of Immunotherapy, 2004
- Immunogenicity and Therapeutic Efficacy of Dendritic–Tumor Hybrid Cells Generated by ElectrofusionClinical Immunology, 2002
- CD19+ B lymphocytes are the major source of human antibody-secreting hybridomas generated by electrofusionJournal of Immunological Methods, 2001
- The dendritic cell and human cancer vaccinesCurrent Opinion in Immunology, 2000
- Electromanipulation of mammalian cells: fundamentals and applicationIEEE Transactions on Plasma Science, 2000
- Enhanced hybridoma production by electrofusion in strongly hypo-osmolar solutionsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1989